Light therapies for acne.
BACKGROUND
Acne vulgaris is a very common skin problem that presents with blackheads, whiteheads, and inflamed spots. It frequently results in physical scarring and may cause psychological distress. The use of oral and topical treatments can be limited in some people due to ineffectiveness, inconvenience, poor tolerability or side-effects. Some studies have suggested promising results for light therapies.


OBJECTIVE
To explore the effects of light treatment of different wavelengths for acne.


METHODS
We searched the following databases up to September 2015: the Cochrane Skin Specialised Register, CENTRAL, MEDLINE, Embase and LILACS. We searched ISI Web of Science and Dissertation Abstracts International (from inception). We also searched five trials registers, and grey literature sources. We checked the reference lists of studies and reviews and consulted study authors and other experts in the field to identify further references to relevant randomised controlled trials (RCTs). We updated these searches in July 2016 but these results have not yet been incorporated into the review.


METHODS
We included RCTs of light for treatment of acne vulgaris, regardless of language or publication status.


METHODS
We used standard methodological procedures expected by Cochrane.


RESULTS
We included 71 studies, randomising a total of 4211 participants.Most studies were small (median 31 participants) and included participants with mild to moderate acne of both sexes and with a mean age of 20 to 30 years. Light interventions differed greatly in wavelength, dose, active substances used in photodynamic therapy (PDT), and comparator interventions (most commonly no treatment, placebo, another light intervention, or various topical treatments). Numbers of light sessions varied from one to 112 (most commonly two to four). Frequency of application varied from twice daily to once monthly.Selection and performance bias were unclear in the majority of studies. Detection bias was unclear for participant-assessed outcomes and low for investigator-assessed outcomes in the majority of studies. Attrition and reporting bias were low in over half of the studies and unclear or high in the rest. Two thirds of studies were industry-sponsored; study authors either reported conflict of interest, or such information was not declared, so we judged the risk of bias as unclear.Comparisons of most interventions for our first primary outcome 'Participant's global assessment of improvement' were not possible due to the variation in the interventions and the way the studies' outcomes were measured. We did not combine the effect estimates but rated the quality of the evidence as very low for the comparison of light therapies, including PDT to placebo, no treatment, topical treatment or other comparators for this outcome. One study which included 266 participants with moderate to severe acne showed little or no difference in effectiveness for this outcome between 20% aminolevulinic acid (ALA)-PDT (activated by blue light) versus vehicle plus blue light (risk ratio (RR) 0.87, 95% confidence interval (CI) 0.72 to 1.04, low-quality evidence). A study (n = 180) of a comparison of ALA-PDT (activated by red light) concentrations showed 20% ALA was no more effective than 15% (RR 1.05, 95% CI 0.96 to 1.15) but better than 10% ALA (RR 1.22, 95% CI 1.05 to 1.42) and 5% ALA (RR 1.47, 95% CI 1.19 to 1.81). The number needed to treat for an additional beneficial outcome (NNTB) was 6 (95% CI 3 to 19) and 4 (95% CI 2 to 6) for the comparison of 20% ALA with 10% and 5% ALA, respectively.For our second primary outcome 'Investigator-assessed changes in lesion counts', we combined three RCTs, with 360 participants with moderate to severe acne and found methyl aminolevulinate (MAL) PDT (activated by red light) was no different to placebo cream plus red light with regard to change in inflamed lesions (ILs) (mean difference (MD) -2.85, 95% CI -7.51 to 1.81), percentage change in ILs (MD -10.09, 95% CI -20.25 to 0.06), change in non-inflamed lesions (NILs) (MD -2.01, 95% CI -7.07 to 3.05), or in percentage change in NILs (MD -8.09, 95% CI -21.51 to 5.32). We assessed the evidence as moderate quality for these outcomes meaning that there is little or no clinical difference between these two interventions for lesion counts.Studies comparing the effects of other interventions were inconsistent or had small samples and high risk of bias. We performed only narrative synthesis for the results of the remaining trials, due to great variation in many aspects of the studies, poor reporting, and failure to obtain necessary data. Several studies compared yellow light to placebo or no treatment, infrared light to no treatment, gold microparticle suspension to vehicle, and clindamycin/benzoyl peroxide combined with pulsed dye laser to clindamycin/benzoyl peroxide alone. There were also several other studies comparing MAL-PDT to light-only treatment, to adapalene and in combination with long-pulsed dye laser to long-pulsed dye laser alone. None of these showed any clinically significant effects.Our third primary outcome was 'Investigator-assessed severe adverse effects'. Most studies reported adverse effects, but not adequately with scarring reported as absent, and blistering reported only in studies on intense pulsed light, infrared light and photodynamic therapies. We rated the quality of the evidence as very low, meaning we were uncertain of the adverse effects of the light therapies.Although our primary endpoint was long-term outcomes, less than half of the studies performed assessments later than eight weeks after final treatment. Only a few studies assessed outcomes at more than three months after final treatment, and longer-term assessments are mostly not covered in this review.


CONCLUSIONS
High-quality evidence on the use of light therapies for people with acne is lacking. There is low certainty of the usefulness of MAL-PDT (red light) or ALA-PDT (blue light) as standard therapies for people with moderate to severe acne.Carefully planned studies, using standardised outcome measures, comparing the effectiveness of common acne treatments with light therapies would be welcomed, together with adherence to the Consolidated Standards of Reporting Trials (CONSORT) guidelines.
Andrija Stampar School of Public Health, School of Medicine, University of Zagreb, Rockefellerova 4, Zagreb, Croatia, 10000.
Jelena
J
Barbaric
Rachel
R
Abbott
Pawel
P
Posadzki
Mate
M
Car
Laura H
LH
Gunn
Alison M
AM
Layton
Azeem
A
Majeed
Josip
J
Car
Isr J Chem. 2012 Sep;52(8-9):691-705
23248387
J Am Acad Dermatol. 2010 Aug;63(2):183-93; quiz 193-4
20633796
Arch Dermatol. 1982 Jan;118(1):23-5
6460474
Arch Dermatol Res. 2014 Apr;306(3):269-77
23925586
Clin Dermatol. 2004 Sep-Oct;22(5):367-74
15556720
Lasers Surg Med. 2007 Feb;39(2):193-8
16983674
BMJ Open. 2015 Jul 17;5(7):e008085
26187120
Br J Dermatol. 2009 Jan;160(1):132-6
19067711
Br J Dermatol. 2006 May;154(5):969-76
16634903
Photodermatol Photoimmunol Photomed. 2004 Oct;20(5):266-9
15379878
Am J Clin Dermatol. 2006;7(5):281-90
17007539
J Cosmet Dermatol. 2010 Mar;9(1):28-34
20367670
J Invest Dermatol. 2000 Aug;115(2):183-92
10951234
J Drugs Dermatol. 2008 Jul;7(7):627-32
18664153
Br J Dermatol. 2009 Jun;160(6):1273-85
19239470
Dermatol Surg. 2005 Oct;31(10):1290-6
16188181
J Drugs Dermatol. 2003 Aug;2(4):393-6
12884461
Br J Dermatol. 2016 Feb;174(2):287-95
26779929
J Am Acad Dermatol. 2010 Aug;63(2):195-211; quiz 211-2
20633797
Cochrane Database Syst Rev. 2012 Jul 11;(7):CD004425
22786490
Exp Ther Med. 2015 Sep;10(3):1194-1198
26622463
Photodermatol Photoimmunol Photomed. 2013 Oct;29(5):233-8
24001378
PLoS Med. 2009 Jul 21;6(7):e1000097
19621072
J Eur Acad Dermatol Venereol. 2006 Nov;20(10):1287-95
17062047
Cochrane Database Syst Rev. 2001;(1):CD001866
11279732
Indian Dermatol Online J. 2015 May-Jun;6(3):145-57
26009707
Br J Dermatol. 2010 Nov;163(5):1064-71
20491770
J Dtsch Dermatol Ges. 2007 Apr;5(4):316-23
17376098
J Eur Acad Dermatol Venereol. 2011 Apr;25(4):454-61
20659307
Dermatol Surg. 2014 Apr;40(4):359-77
24495252
Trials. 2010 Jul 12;11:77
20624287
BMJ. 2010 Mar 23;340:c332
20332509
Br J Dermatol. 2011 Dec;165(6):1256-62
21910712
J Eur Acad Dermatol Venereol. 2010 Jul;24(7):773-80
20002654
J Dermatolog Treat. 2012 Feb;23(1):35-6
21254857
J Dermatol. 2015 Jul;42(7):690-6
25916427
PLoS Med. 2006 Nov;3(11):e483
17121451
Semin Pediatr Surg. 2005 May;14(2):111-7
15846568
J Drugs Dermatol. 2005 Jan-Feb;4(1):64-70
15696987
Indian J Dermatol. 2012 Mar;57(2):128-30
22615511
Br J Dermatol. 2016 Apr;174(4):770-7
26663215
J Drugs Dermatol. 2010 Mar;9(3):229-33
20232583
Int J Dermatol. 2013 May;52(5):614-9
23046014
J Cosmet Laser Ther. 2008 Dec;10(4):213-6
18608702
Dermatol Surg. 2016 Mar;42(3):403-9
26890802
J Drugs Dermatol. 2007 Oct;6(10):1010-6
17966178
J Cosmet Laser Ther. 2009 Jun;11(2):118-24
19391056
J Cosmet Laser Ther. 2010 Dec;12(6):276-83
21142737
J Am Acad Dermatol. 2008 Mar;58(3):387-94
18280335
J Cosmet Laser Ther. 2003 Jun;5(2):111-7
12850803
Photodermatol Photoimmunol Photomed. 2013 Apr;29(2):90-6
23458393
Ann Intern Med. 2004 Nov 16;141(10):781-8
15545678
J Cutan Med Surg. 2010 Jul-Aug;14(4):156-60
20642983
J Am Acad Dermatol. 1992 Jun;26(6):931-5
1535079
J Dermatolog Treat. 2014 Apr;25(2):142-6
23336106
J Dermatol. 2016 May;43(5):515-21
26660491
Photodermatol Photoimmunol Photomed. 2005 Dec;21(6):322-5
16313244
Cutis. 2002 Aug;70(2):133-9
12234161
Br J Dermatol. 2004 Sep;151(3):616-22
15377348
Cochrane Database Syst Rev. 2015 Jan 19;1:CD009436
25597924
J Am Acad Dermatol. 2014 Oct;71(4):764-71
24930587
Arch Dermatol. 1988 Jun;124(6):869-71
3377516
J Am Acad Dermatol. 2007 Mar;56(3):432-8
17239987
Dermatol Surg. 2007 Jun;33(6):676-9
17550443
J Drugs Dermatol. 2009 Nov;8(11):1010-9
19894368
Cochrane Database Syst Rev. 2012 Aug 15;(8):CD002086
22895927
Dermatol Surg. 2009 Dec;35(12):1918-26
19708873
Br J Dermatol. 1997 Jan;136(1):66-70
9039297
Br J Dermatol. 2013 Mar;168(3):474-85
23210645
J Cosmet Laser Ther. 2012 Oct;14(5):212-7
23016530
Dermatol Surg. 2014 Nov;40(11):1191-200
25310750
Best Pract Res Clin Obstet Gynaecol. 2004 Oct;18(5):737-54
15380144
J Drugs Dermatol. 2010 Nov;9(11):1347-52
21061756
Dermatol Surg. 2007 Oct;33(10):1228-33; discussion 1233
17903156
J Eur Acad Dermatol Venereol. 2008 Mar;22(3):267-78
18221341
J Cosmet Laser Ther. 2015;17(4):170-6
25594129
Lasers Surg Med. 2011 Mar;43(3):200-5
21412803
BMJ. 2005 Oct 15;331(7521):897-900
16223826
J Am Acad Dermatol. 2006 May;54(5 Suppl):S235-6
16631951
J Eur Acad Dermatol Venereol. 2013 Jun;27(6):672-9
23181556
Arch Dermatol. 1998 Mar;134(3):376-8
9521042
An Bras Dermatol. 2009 Sep-Oct;84(5):463-8
20098847
Br J Dermatol. 2009 Jun;160(6):1140-8
19239465
J Clin Aesthet Dermatol. 2016 Mar;9(3):25-35
27354885
Dermatol Surg. 2005 Aug;31(8 Pt 1):910-5
16042935
Br Med J. 1979 Apr 28;1(6171):1109-10
156054
Br J Dermatol. 2013 May;168(5):1088-94
23278295
J Eur Acad Dermatol Venereol. 2012 Feb;26 Suppl 1:1-29
22356611
Lancet. 2003 Oct 25;362(9393):1347-52
14585635
J Eur Acad Dermatol Venereol. 2010 Apr;24(4):460-9
19796088
Clin Exp Dermatol. 2011 Mar;36(2):119-22; quiz 123
20738323
Br J Dermatol. 2010 Aug;163(2):395-401
20394631
J Am Acad Dermatol. 2006 Apr;54(4):647-51
16546587
Lasers Surg Med. 2002;31(2):115-20
12210595
JAMA. 2004 Jun 16;291(23):2834-9
15199033
Dermatol Surg. 2009 Aug;35(8):1181-7
19175372
Lasers Surg Med. 2007 Jan;39(1):1-6
17252567
Br J Dermatol. 2013 Oct;169 Suppl 3:91-7
24098905
J Cutan Med Surg. 2004;8 Suppl 4:3-5
15778823
J Drugs Dermatol. 2006 Jan;5(1):45-55
16468292
Photodiagnosis Photodyn Ther. 2013 Dec;10(4):583-90
24284115
Clin Dermatol. 2004 Sep-Oct;22(5):419-28
15556729
J Am Acad Dermatol. 2009 May;60(5 Suppl):S1-50
19376456
J Biomed Opt. 2004 Jul-Aug;9(4):828-34
15250771
J Eur Acad Dermatol Venereol. 2013 Sep;27(9):1063-70
23302006
Skin Therapy Lett. 2004 Aug-Sep;9(7):1-3, 9
15334275
J Cutan Med Surg. 2012 Sep-Oct;16(5):324-33
22971307
Br J Dermatol. 2000 May;142(5):973-8
10809858
Arch Dermatol. 1977 Jan;113(1):31-6
137693
J Dermatolog Treat. 2005;16(4):219-23
16249142
Dermatol Surg. 2006 Aug;32(8):991-6; discussion 996-7
16918560
Indian J Dermatol Venereol Leprol. 2013 Jan-Feb;79(1):77-82
23254733
Br J Dermatol. 1971 Aug;85(2):119-26
4255129
J Drugs Dermatol. 2009 Nov;8(11):983-90
19894365
J Am Acad Dermatol. 2012 Apr;66(4):626-33
22033354
Int J Dermatol. 2010 Apr;49(4):448-56
20465705
J Am Acad Dermatol. 2016 May;74(5):945-73.e33
26897386
J Am Acad Dermatol. 2006 Jul;55(1):80-7
16781297
Photodermatol Photoimmunol Photomed. 2014 Oct;30(5):246-53
24313686
Br J Dermatol. 2006 Sep;155(3):608-13
16911289
Arch Dermatol Res. 2016 May;308(4):263-8
26993345
Lancet. 2012 Jan 28;379(9813):361-72
21880356
Br J Dermatol. 2002 May;146(5):840-8
12000382
Clin Dermatol. 2004 Sep-Oct;22(5):360-6
15556719
Dermatol Surg. 2006 Feb;32(2):249-55; discussion 255
16442046
Dermatol Surg. 2007 May;33(5):552-9
17451577
J Am Acad Dermatol. 2013 Oct;69(4):609-615.e8
23711766
N Engl J Med. 1989 Apr 13;320(15):1007-9
2522591
J Eur Acad Dermatol Venereol. 2012 Mar;26(3):277-82
21848892
Lasers Surg Med. 2005 Dec;37(5):333-42
16365889
J Lasers Med Sci. 2015 Fall;6(4):167-70
26705462
J Dermatol. 2012 Aug;39(8):728-9
22385206
J Cosmet Laser Ther. 2011 Dec;13(6):303-7
21981360
Lasers Surg Med. 2006 Mar;38(3):177-80
16180221
Lasers Surg Med. 2003;33(5):296-310
14677157
Expert Opin Drug Saf. 2004 Mar;3(2):119-29
15006718
J Cosmet Laser Ther. 2011 Dec;13(6):308-14
22091799
Br J Dermatol. 1998 Nov;139(5):840-5
9892951
N Engl J Med. 1985 Oct 3;313(14):837-41
3162101
Med Sci Monit. 2016 Feb 03;22:362-6
26839152
Clin Exp Dermatol. 1994 Jul;19(4):303-8
7955470
J Invest Dermatol. 2015 Jul;135(7):1727-1734
25748556
Dermatol Ther. 2005 May-Jun;18(3):253-66
16229726
J Dermatol. 2009 Jan;36(1):17-21
19207432
Arch Dermatol. 1998 Feb;134(2):207-14
9487213
Lasers Surg Med. 2010 Feb;42(2):171-8
20166163
BMJ. 2003 Sep 6;327(7414):557-60
12958120
J Cosmet Laser Ther. 2013 Oct;15(5):248-54
23789838